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Mature T  lymphocytes can be activated through either the T3-Ti molecular 
complex  (1)  or  the  T1 1  structure  (2)  to  undergo  proliferation  and  mediate 
various regulatory functions. While the natural ligand for the former is clearly 
antigen  and  MHC,  the  natural  ligand  of the  T1 1  structure  has  only recently 
been identified (3).  In  this regard,  it has been shown  that a  novel lymphokine 
with an apparent molecular mass of 10-12 kD is secreted from Th clones within 
hours  after  crosslinking  of  their  antigen/MHC  receptors.  This  lymphokine, 
herein termed T  cell activating factor (TCAF), ~ stimulates resting T  lymphocytes 
via binding to surface components of the alternative T 1 1 pathway. The activation 
process is not dependent on either antigen specificities of recruited populations 
or  the  presence  of  macrophages  and  IL-1.  It  thus  appears  that  TCAF  is  a 
mediator involved in amplifying the T  cell immune response through recruitment 
of other cellular components of the lymphoid system. 
mAbs directed against  spatially distinct epitopes of the T 11  molecule (T 1 12 
and T 1 13) were previously shown (4) to cause an antigen-independent activation 
of the cytolytic mechanism of CTL (as evidenced by the induction of nonspecific 
cytolytic activity). In addition,  T1 I+T3-Ti  -  NK cell clones are induced by the 
same antibodies to cause lysis of NK-resistant targets.  Collectively, these results 
indicated  that  T1 1  triggering  could activate cytotoxic lymphocytes to express 
their functional programs in the absence of specific antigen recognition via the 
T3-Ti complex. This raised the possibility that TCAF might modulate cytotoxic 
effector function as well. 
Materials and Methods 
Clones.  The  NK  and  T  cell clones  used  in  this  work  were  isolated  as  previously 
reported (4, 5) and their characterization is presented in Table I. In brief, QQ and AA8 
are alloreactive cytotoxic T cell clones from two different donors. Clone QQ (4) is specific 
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TABLE  I 
Characterization of Cytotoxic and Natural Killer Clones 
Clones  Function  Phenotype  Cytotoxic specificity  Reference 
QQ  CTL  T3+T4-T8+T11 +NKH 1  -  HLA-B7  4 
AA8  CTL  T3+T4+T8-T 11 +NKH 1-  HLA-Dr7 or Dr4  6 
JT10  NK  T3+T4-T8+T1 I+NKHI +  140KD TNKTAR  5 
CNK6  NK  T3-T4-T8-T  11 +NKH 1  +  Non-MHC  5 
for the HLA-B7 molecule on the allogeneic EBV-transformed B cell line Laz  156  (HLA 
genotype: A2, A3, B7, B40, Dr2, and Dr4), while clone AA8 (6) is directed at the HLA 
class II molecules on the allogeneic B lymphoblastoid line Laz 509 (A2, A25, B13, Bw38, 
Dr4, and Dr7). 
The NK clones (5) were derived from the peripheral blood of the same individual and 
were  selected  for  their  ability  to  kill  K562  target  cells  without  prior  immunization. 
Cytotoxicity of these clones cannot be blocked by mAbs specific for class  I  or class  II 
MHC products (7). CloneJT 10 has been shown to be specific for a cell surface glycoprotein 
of 140 kD (TNKvAR) expressed on lymphoid and hematopoietic cells after activation (8). 
Furthermore, its cytotoxicity is also blocked by antibody to T3. Unlike JT 10, the CNK6 
clone is not specific for the TNKxAR antigen and does not express the T3 surface marker. 
Functional Assays.  Cytotoxic activity was measured using a standard 5~Cr release assay 
(9) in which effector clones and labeled target cells were mixed at a  1:1-10:1  E/T ratio 
in a final volume of 0.2  ml. After centrifugation, assay plates were incubated for 4 h at 
37 °C before removal of aliquots of supernatant for detection of radioactivity. 
Lymphokines  and  mAbs.  The  mAbs  anti-Tll2  (IgG2a)  and  anti-Tll3  (IgG3)  were 
produced and characterized as described elsewhere (2) and were used in ascites form at a 
1:100 final dilution.  Recombinant human  IL-1 (a generous gift of Dr.  C.  A.  Dinarello, 
Tufts  Medical  School,  Boston,  MA)  was  used  at  a  final  concentration  of 25  U/ml,  a 
concentration well in excess of that required for optimal activity in a murine thymocyte 
proliferation  assay,  rIL-2  and  rlFN-~,  (Biogen,  Cambridge,  MA)  were  used  at  final 
concentrations  of  1000  U/ml.  Partially purified  TCAF  was obtained as described and 
used  at  4  U/ml  (3).  Briefly,  Th  supernatant  was  subjected  to  a  90%  saturation  of 
ammonium sulfate  and  the  redissolved  precipitate  was  applied  to  a  Sephadex  G-100 
molecular sieve column.  Fractions containing  TCAF activity were pooled and conceno 
trated,  and  subjected  to further  molecular sieve chromatography on a  Sephadex G-50 
column. The fractions containing TCAF were again pooled and concentrated,  yielding 
~35%  of the  TCAF  activity  when  compared with  the  original  supernatant,  but  were 
devoid of IL-2 activity. 
Results and  Discussion 
To determine whether TCAF could induce antigen-independent activation of 
the  cytolytic  mechanism,  a  series  of experiments  was  performed  using  clonal 
cytotoxic effector populations.  QQ  is a  representative T3+T4-T8 + cytotoxic T 
cell clone specific for the  HLA-B7 molecule expressed by the  B lymphoblastoid 
line  Laz  156.  As  shown  in  Fig.  1A,  in  the  absence  of anti-Tll  antibodies  or 
TCAF,  this clone will  lyse Laz  156  cells but not  Laz 509,  an  EBV-transformed 
B  cell  line  derived  from  a  donor  of a  different  HLA  genotype.  As previously 
reported,  the presence of a  combination of anti-T 112  and anti-T 11 ~ antibodies 
induced clone QQ to lyse the inappropriate target Laz 509.  A  similar effect was 
observed with the purified TCAF lymphokine (4 U/ml). In contrast, purified IL- 
l,  IL-2, or  IFN-'y could  not  induce a  cytotoxic response against  Laz  509  cells. 
Although  not  shown,  serial  dilution  of the  TCAF  material  resulted  in  a  dose- 
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FIGURE  1.  Lysis of 5aCt-labeled B lymphoblastoid target cell lines Laz 509 and Laz  156 by 
the alloreactive cytotoxic T  cell clones QQ (A) and AA8 (B).  QQ is a CTL clone specific for 
an MHC class I antigen expressed on Laz 156 and lacking on Laz 509, whereas AA8 is directed 
to an MHC class I1 antigen present on Laz 509 (E/T ratio,  1:1).  In these experiments, units 
of lymphokines are as follows: IL-I, 25 U/ml; IL-2,  1,000 U/ml; IFN-'y,  1,000 U/ml); TCAF 
(I L-4), 4 U/ml. A unit of TCAF is equivalent to the concentration of lymphokine necessary to 
obtain 50% of the maximum proliferation in a proliferative assay of resting T  lymphocytes. 
was induced by any of the other three lymphokines, even when doses of recom- 
binant material ranging from  1-1,000 U/ml were assayed in the system. 
As shown in  Fig.  1 B, the  T3+T4+T8 -  cytotoxic T  cell clone AA8,  which  is 
specific for a  class II molecule on  Laz 509 but lacking on Laz  156 cells, could 
kill the latter in the presence of either anti-T11  antibodies or TCAF. Consistent 
with the above result for the T8 + clone QQ, the other lymphokines assayed in 
this system again could not induce cytotoxic effector function against the irrele- 
vant target cell. Thus, CTL effector function of both T4 + and T8 + CTL clones 
is uniquely regulated by either TCAF or anti-T11  antibodies. 
The induction of antigen-independent  cytotoxicity via the TCAF lymphokine 
results from the action of the lymphokine on the cytotoxic T  cell clones since: 
(a) TCAF does not  induce  lysis of target  cells in  the absence of CTL  and  (b) 
target  cells  do  not  express  the  T11  molecules,  which  is  the  putative  TCAF 
surface receptor (data not shown).  Furthermore,  the effect of TCAF could be 
observed if CTL were pretreated with the lymphokine.  Although not shown, it 
was found that TCAF-induced cytotoxicity, like anti-T11-induced  cytotoxicity, 
was not mediated by clones whose active genetic program  lacked the cytotoxic 
machinery. This is not surprising in view of the fact that prior studies with anti- 
T11  indicated  that  cytotoxicity occurs  through  effector mechanisms  virtually 
identical  to  those  involved  in  specific  cytotoxicity, including  calcium  require- 
ments, temperature sensitivity, and cell contact dependence (4). 
NK cells are operationally defined as those capable of mediating direct cyto- 
toxicity against  various target  cell  types without apparent  prior  immunization. 
NK cells are not restricted by the MHC antigens expressed on their target cells. 
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FIGURE 2.  Effects of TCAF and anti-Tl 12 + anti-T113 antibodies on lytic effector functions 
of NK clones.  Both the T3+JT10  NK clone (A) and the T3- CNK6  NK clone (B) (selected 
for their ability to kill the NK target K562) are induced by anti-T112 +  anti-T1 ls antibodies 
(1:100 final dilution) or TCAF (4  U/ml) to lyse the NK-resistant target Laz 509 (E/T ratio, 
10:1). 
contain  Ti  alpha  and  Ti  beta  mRNA  transcripts  and  express  disulfide-linked 
heterodimers on the cell surface, consistent with the presence of a functional T 
cell receptor.  In contrast, T1 l÷T3 -  NK clones express only truncated  1.0 kb Ti 
beta transcripts  without Ti  alpha  transcripts  and  possess no detectable surface 
Ti protein.  Since prior studies showed that Ti beta gene activation precedes Ti 
alpha gene activation  within  the thymus (10), the T1 l+T3 -  NK cells appear to 
be derived from T  lineage precursors.  The ability of anti-T11  antibodies (4) to 
trigger cytotoxic activity from NK clones further supports this notion. 
To determine  whether  TCAF  would activate  representative  NK  clones,  we 
examined the non-MHC-restricted T3-T 11 + NK clone CNK6 and the T3+T 11 + 
NK  clone JT10,  previously  shown  to  be  specific for  the  non-MHC-restricted 
target  antigen  TNKTAR  (a  140  kD  glycoprotein  that  is  widely  expressed  on 
normal  lymphoid and hematopoietic cells after activation).  As shown in  Fig.  2, 
both JT10 and  CNK6 (Fig.  2, A and B, respectively) efficiently killed the  NK 
susceptible target K562. In contrast, neither clone by itself was cytotoxic for the 
NK-resistant B lympboblastoid line Laz 509. The addition of anti-T 112 and anti- 
T 1 ! 3 antibody or TCAF, however, induced lysis of the NK-resistant target  Laz 
509.  The  ability  to  induce  killing  activity  from  cells  that  lack  a  T3-Ti  anti- 
gen/MHC receptor complex by triggering  through  the T11 structure, as in the 
case of CNK6, further substantiates the view that the T 11  molecule represents 
an independent mechanism of cell activation. 
What might be the in  vivo function of the TCAF-mediated induction  of the 
killing machinery of clones with cytotoxic potential, given that it is independent 
of antigen  specificity? One likely possibility is that  TCAF functions as a  vector 
for amplifying cellular immune responses of both effector and regulatory types. 
In the case of the CTL described here, it is likely that TCAF may be the basis 
by  which  the  T  cell  immune  system  can  maintain  millions  of CTL  receptor 
specificities for various antigens on target cells by virtue of unique Ti alpha-beta 
V  domain  combinations, and  still  provide protective immunity against virus or MILANESE ET  AL.  BRIEF  DEFINITIVE  REPORT  1587 
other  pathogen  infected  cells,  benign  or  malignant.  While  there  must  exist 
homeostatic controls to terminate TCAF-mediated cytotoxicity, it is not unrea- 
sonable to assume that the lymphokine itself may be functioning exclusively over 
short distances and facilitates cytotoxicity in infected tissues once antigen-specific 
Th have been triggered. 
In the case of the NK populations, it would appear that the T  cell product, 
like the anti-T112  +  anti-T113  antibodies (4,  11),  can  facilitate recruitment in 
several ways. First, TCAF can function to directly induce a  given NK clone to 
express its cytolytic program.  Second, by virtue of the fact that TCAF induces 
IL-2-R expression on T11 ÷ cells (3), and consequently IL-2 responsiveness, the 
TCAF lymphokine will presumably lead to clonal expansion of these cells. The 
recent observations regarding IL-2-inducible NK cells (so called LAK cells) (I 2, 
13) are most likely a consequence of such an increase in the number of effector 
cells expressing IL-2 receptors. Emphasis should be placed, however, on the fact 
that IL-2, unlike TCAF, does not directly stimulate the cytotoxic program of a 
given activated CTL (see  Fig.  1) or  NK clone (data not shown).  Furthermore, 
IL-2  stimulation does  not  result  in  alteration of clonal  specificity.  Additional 
analysis of the effects of TCAF on heterogeneous peripheral blood T  and NK 
populations and production  of neutralizing anti-TCAF antibodies  will  further 
elucidate the physiology of TCAF with respect to cytotoxic effector function. 
Summary 
A  10-12  kD  lymphokine,  herein  termed  TCAF,  was  recently shown  to  be 
secreted  from Th  after crosslinking of their antigen/MHC (T3-Ti)  receptors. 
TCAF  stimulates  resting  T  lymphocyte proliferation  via  binding  to  surface 
components of the T1 1 pathway. To determine whether TCAF could induce 
antigen-independent  activation  of the  lytic  machinery  of cytotoxic  cells,  the 
present  studies  were  conducted.  In  the  presence  of TCAF,  both  T8 +  class  I 
MHC-specific and T4 + class II MHC-specific cytotoxic T  cell clones were induced 
to  kill  targets,  including those  lacking the  appropriate  MHC  molecules.  This 
effect was  unique to TCAF,  since  IL-1,  IL-2,  IFN-',/ could not stimulate lytic 
activity. Furthermore, both T3+T1 1  + and T3-T11 + NK clones were triggered 
to lyse NK-resistant target cells. These findings suggest that TCAF can function 
in an antigen-independent fashion to amplify cytotoxic effector responses. 
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